Loading...
Header Logo
Keywords
Last Name
Institution

Dr Getnet Yimer

TitleAdjunct Associate Professor
InstitutionThe Ohio State University
DepartmentInternal Medicine
AddressUnited States
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Getnet Yimer, MD, PhD
    Eastern Africa Regional Director
    Global One Health Initiative
    Office of International Affairs | The Ohio State University
    +251-911-405-387
    https://oia.osu.edu/global-one-health
    yimer.4@osu.edu oia.osu.edu


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Ahmed JH, Makonnen E, Fotoohi A, Yimer G, Seifu D, Assefa M, Tigeneh W, Aseffa A, Howe R, Aklillu E. Vitamin D Status and Association of VDR Genetic Polymorphism to Risk of Breast Cancer in Ethiopia. Nutrients. 2019 Jan 29; 11(2). PMID: 30699973.
      View in: PubMed
    2. Gutierrez MM, Pillai G, Felix S, Romero F, Onyango KO, Owusu-Agyei S, Asante KP, Barnes KI, Sinxadi P, Allen E, Abdulla S, Masimirembwa C, Munyoro M, Yimer G, Gebre-Mariam T, Spector J, Ogutu B. Building Capability for Clinical Pharmacology Research in Sub-Saharan Africa. Clin Pharmacol Ther. 2017 Nov; 102(5):786-795. PMID: 28378903.
      View in: PubMed
    3. Petros Z, Lee MT, Takahashi A, Zhang Y, Yimer G, Habtewold A, Schuppe-Koistinen I, Mushiroda T, Makonnen E, Kubo M, Aklillu E. Genome-Wide Association and Replication Study of Hepatotoxicity Induced by Antiretrovirals Alone or with Concomitant Anti-Tuberculosis Drugs. OMICS. 2017 04; 21(4):207-216. PMID: 28388302.
      View in: PubMed
    4. Bedewi Z, Mekonnen Y, Worku A, Medhin G, Zewde A, Yimer G, Pieper R, Ameni G. Mycobacterium tuberculosis in central Ethiopia: drug sensitivity patterns and association with genotype. New Microbes New Infect. 2017 May; 17:69-74. PMID: 28377803.
      View in: PubMed
    5. Bedewi Z, Worku A, Mekonnen Y, Yimer G, Medhin G, Mamo G, Pieper R, Ameni G. Molecular typing of Mycobacterium tuberculosis complex isolated from pulmonary tuberculosis patients in central Ethiopia. BMC Infect Dis. 2017 03 01; 17(1):184. PMID: 28249607.
      View in: PubMed
    6. Petros Z, Kishikawa J, Makonnen E, Yimer G, Habtewold A, Aklillu E. HLA-B*57 Allele Is Associated with Concomitant Anti-tuberculosis and Antiretroviral Drugs Induced Liver Toxicity in Ethiopians. Front Pharmacol. 2017; 8:90. PMID: 28289388.
      View in: PubMed
    7. Aseffa A, Chukwu JN, Vahedi M, Aguwa EN, Bedru A, Mebrahtu T, Ezechi OC, Yimer G, Yamuah LK, Medhin G, Connolly C, Rida W, Aderaye G, Zumla AI, Onyebujoh PC. Efficacy and Safety of 'Fixed Dose' versus 'Loose' Drug Regimens for Treatment of Pulmonary Tuberculosis in Two High TB-Burden African Countries: A Randomized Controlled Trial. PLoS One. 2016; 11(6):e0157434. PMID: 27322164.
      View in: PubMed
    8. Habtewold A, Aklillu E, Makonnen E, Amogne W, Yimer G, Aderaye G, Bertilsson L, Owen JS, Burhenne J. Long-Term Effect of Rifampicin-Based Anti-TB Regimen Coadministration on the Pharmacokinetic Parameters of Efavirenz and 8-Hydroxy-Efavirenz in Ethiopian Patients. J Clin Pharmacol. 2016 12; 56(12):1538-1549. PMID: 27125860.
      View in: PubMed
    9. Girma B, Yimer G, Makonnen E. Effect of Rumex Abyssinicus on preneoplastic lesions in dimethylhydrazine induced colon carcinogenesis in rats. BMC Complement Altern Med. 2015 Oct 15; 15:365. PMID: 26470793.
      View in: PubMed
    10. Ng LC, Hanlon C, Yimer G, Henderson DC, Fekadu A. Ethics in global health research: the need for balance. Lancet Glob Health. 2015 Sep; 3(9):e516-7. PMID: 26275322.
      View in: PubMed
    11. Amogne W, Aderaye G, Habtewold A, Yimer G, Makonnen E, Worku A, Sonnerborg A, Aklillu E, Lindquist L. Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/µL: TB-HAART Study, a Randomized Clinical Trial. PLoS One. 2015; 10(5):e0122587. PMID: 25966339.
      View in: PubMed
    12. Habtewold A, Makonnen E, Amogne W, Yimer G, Aderaye G, Bertilsson L, Burhenne J, Aklillu E. Is there a need to increase the dose of efavirenz during concomitant rifampicin-based antituberculosis therapy in sub-Saharan Africa? The HIV-TB pharmagene study. Pharmacogenomics. 2015; 16(10):1047-64. PMID: 25831219.
      View in: PubMed
    13. Fiseha D, Kumssa H, Tefera M, Tesfaye A, Klinkenberg E, Yimer G. Ambulatory care for multidrug-resistant tuberculosis: lessons learned in Addis Ababa, Ethiopia. Public Health Action. 2014 Dec 21; 4(Suppl 3):S37-41. PMID: 26478512.
      View in: PubMed
    14. Fekadu A, Teferra S, Hailu A, Gebre-Mariam T, Addissie A, Deressa W, Yimer G, Reja A. International Clinical Trial Day and clinical trials in Ethiopia and Africa. Trials. 2014 Dec 19; 15:493. PMID: 25526797.
      View in: PubMed
    15. Mfinanga SG, Kirenga BJ, Chanda DM, Mutayoba B, Mthiyane T, Yimer G, Ezechi O, Connolly C, Kapotwe V, Muwonge C, Massaga J, Sinkala E, Kohi W, Lyantumba L, Nyakoojo G, Luwaga H, Doulla B, Mzyece J, Kapata N, Vahedi M, Mwaba P, Egwaga S, Adatu F, Pym A, Joloba M, Rustomjee R, Zumla A, Onyebujoh P. Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial. Lancet Infect Dis. 2014 Jul; 14(7):563-71. PMID: 24810491.
      View in: PubMed
    16. Yimer G, Gry M, Amogne W, Makonnen E, Habtewold A, Petros Z, Aderaye G, Schuppe-Koistinen I, Lindquist L, Aklillu E. Evaluation of patterns of liver toxicity in patients on antiretroviral and anti-tuberculosis drugs: a prospective four arm observational study in ethiopian patients. PLoS One. 2014; 9(4):e94271. PMID: 24714066.
      View in: PubMed
    17. Aklillu E, Odenthal-Hesse L, Bowdrey J, Habtewold A, Ngaimisi E, Yimer G, Amogne W, Mugusi S, Minzi O, Makonnen E, Janabi M, Mugusi F, Aderaye G, Hardwick R, Fu B, Viskaduraki M, Yang F, Hollox EJ. CCL3L1 copy number, HIV load, and immune reconstitution in sub-Saharan Africans. BMC Infect Dis. 2013 Nov 12; 13:536. PMID: 24219137.
      View in: PubMed
    18. Machado LR, Bowdrey J, Ngaimisi E, Habtewold A, Minzi O, Makonnen E, Yimer G, Amogne W, Mugusi S, Janabi M, Aderaye G, Mugusi F, Viskaduraki M, Aklillu E, Hollox EJ. Copy number variation of Fc gamma receptor genes in HIV-infected and HIV-tuberculosis co-infected individuals in sub-Saharan Africa. PLoS One. 2013; 8(11):e78165. PMID: 24250791.
      View in: PubMed
    19. Thulin P, Nordahl G, Gry M, Yimer G, Aklillu E, Makonnen E, Aderaye G, Lindquist L, Mattsson CM, Ekblom B, Antoine DJ, Park BK, Linder S, Harrill AH, Watkins PB, Glinghammar B, Schuppe-Koistinen I. Keratin-18 and microRNA-122 complement alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts. Liver Int. 2014 Mar; 34(3):367-78. PMID: 24118944.
      View in: PubMed
    20. Ngaimisi E, Habtewold A, Minzi O, Makonnen E, Mugusi S, Amogne W, Yimer G, Riedel KD, Janabi M, Aderaye G, Mugusi F, Bertilsson L, Aklillu E, Burhenne J. Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes: a parallel-group prospective cohort study in two sub-Saharan Africa populations. PLoS One. 2013; 8(7):e67946. PMID: 23861838.
      View in: PubMed
    21. Habtewold A, Amogne W, Makonnen E, Yimer G, Nylén H, Riedel KD, Aderaye G, Bertilsson L, Burhenne J, Diczfalusy U, Aklillu E. Pharmacogenetic and pharmacokinetic aspects of CYP3A induction by efavirenz in HIV patients. Pharmacogenomics J. 2013 Dec; 13(6):484-9. PMID: 23089673.
      View in: PubMed
    22. Hardwick RJ, Amogne W, Mugusi S, Yimer G, Ngaimisi E, Habtewold A, Minzi O, Makonnen E, Janabi M, Machado LR, Viskaduraki M, Mugusi F, Aderaye G, Lindquist L, Hollox EJ, Aklillu E. ß-defensin genomic copy number is associated with HIV load and immune reconstitution in sub-saharan Africans. J Infect Dis. 2012 Oct 01; 206(7):1012-9. PMID: 22837491.
      View in: PubMed
    23. Kirenga BJ, Chanda DM, Muwonge CM, Yimer G, Adatu FE, Onyebujoh PC. Advances in the Diagnosis, Treatment and Control of HIV Associated Tuberculosis. Afr J Infect Dis. 2012; 6(2):29-40. PMID: 23878713.
      View in: PubMed
    24. Yimer G, Ueda N, Habtewold A, Amogne W, Suda A, Riedel KD, Burhenne J, Aderaye G, Lindquist L, Makonnen E, Aklillu E. Pharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patients. PLoS One. 2011; 6(12):e27810. PMID: 22162992.
      View in: PubMed
    25. Yimer G, Amogne W, Habtewold A, Makonnen E, Ueda N, Suda A, Worku A, Haefeli WE, Burhenne J, Aderaye G, Lindquist L, Aklillu E. High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study. Pharmacogenomics J. 2012 Dec; 12(6):499-506. PMID: 21862974.
      View in: PubMed
    26. Habtewold A, Amogne W, Makonnen E, Yimer G, Riedel KD, Ueda N, Worku A, Haefeli WE, Lindquist L, Aderaye G, Burhenne J, Aklillu E. Long-term effect of efavirenz autoinduction on plasma/peripheral blood mononuclear cell drug exposure and CD4 count is influenced by UGT2B7 and CYP2B6 genotypes among HIV patients. J Antimicrob Chemother. 2011 Oct; 66(10):2350-61. PMID: 21846671.
      View in: PubMed
    27. Yimer G, Aderaye G, Amogne W, Makonnen E, Aklillu E, Lindquist L, Yamuah L, Feleke B, Aseffa A. Anti-tuberculosis therapy-induced hepatotoxicity among Ethiopian HIV-positive and negative patients. PLoS One. 2008 Mar 19; 3(3):e1809. PMID: 18350147.
      View in: PubMed
    Yimer's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _